New COVID-19 Variant Stratus Emerges with Unique Symptoms

A new COVID-19 variant, named **Stratus**, is rapidly spreading across the globe, distinguished by a unique early symptom that sets it apart from previous strains. First detected by health officials in **January 2025**, this variant appears in two forms: **XFG** and **XFG.3**. By **June 2025**, the **World Health Organization** (WHO) added XFG to its monitoring list, noting its swift global transmission.

Typical COVID-19 symptoms include fever, cough, and runny nose, often resembling those of other respiratory illnesses. However, the Stratus variant presents a telltale early sign: a **hoarse or raspy voice**. This symptom may appear before more recognizable COVID-19 indicators, making it easily overlooked. Medical professionals have reported additional symptoms associated with Stratus, including sore throats, nasal congestion, digestive issues, and extreme fatigue.

By **summer 2025**, Stratus gained significant traction in the **United States**, becoming the predominant strain. This summer surge was fueled not only by Stratus but also by another variant dubbed **Nimbus**. According to **Dr. Gareth Nye** from the **University of Salford**, “In most ways, it’s almost identical. However, people with this version tend to get very sore throats and a hoarse voice, compared with the other more general symptoms like cough, temperature, and aches.”

Dr. Nye highlighted seasonal illness patterns, noting that spikes in infections often correlate with children returning to school, where close contact and varying hygiene levels can facilitate transmission. He also indicated that the Stratus variant has the ability to partially evade the immune system, potentially diminishing the effectiveness of previous vaccines. This underlines the importance of staying current with COVID-19 vaccinations.

Stratus was first identified in **Southeast Asia** before arriving in the U.S. by **March 2025**. The variant saw a notable increase in cases during **May** and **June**, and by mid-September, it was confirmed as the dominant variant in U.S. wastewater samples. By the end of September, it was estimated that Stratus accounted for **85%** of COVID-19 cases in the country.

The **World Health Organization** has reassured the public that currently approved COVID-19 vaccines are expected to remain effective against severe illness caused by this variant. **Dr. Peter Chin-Hong**, an expert at the **University of California, San Francisco**, warned that Stratus presents a broader range of symptoms than previous strains. “There’s a little bit more sore throats with some people, particularly older adults who didn’t get vaccinated last year,” he stated. He emphasized the variant’s increased transmissibility, predicting a significant number of infections, especially with children returning to school. “A sniffle is likely going to be Covid,” he added.

While the emergence of a new COVID-19 variant may raise concerns, **GOV.UK** reassures that virus mutation is a normal occurrence. The agency is actively collecting data to enhance understanding of the virus and its variants. “It’s normal for viruses to mutate and change, and as more data becomes available on these variants, we’ll have a better understanding of how they interact with our immune systems,” the blog explains. It stresses the importance of vaccinations for those who are eligible.

As the world navigates the ongoing challenges posed by COVID-19, public health authorities continue to advocate for vaccination as a key tool in managing the impact of emerging variants like Stratus.